WHO Technical Report Series, No. 981 - World Health Organization

Acknowledgements
London, England; Dr W. Bukachi, Project Coordinator, International Affairs, US
Pharmacopeia, Rockville, MD, USA; Ms A. Bukirwa, National (Food and) Drug
Authority, Kampala, Uganda; Bureau of Drug and Narcotic, Department of
Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand; Dr F. Burnett,
Managing Director, Pharmaceutical Procurement Service, Organization of
Eastern Caribbean States, Casties, St Lucia; Dr W. Cabri, Research and
Development, Director, Chemistry and Analytical Development, Sigma-tau
Industrie Farmaceutiche Riunite SpA, Pomezia, Italy; Dr. D. Calam, Wiltshire,
England; Dr N. Cappuccino, Lambertville, NJ, USA; Dr A. Castro, Regulatory
Affairs Director and Senior Pharmacist, Roche Servicios SA, Heredia, Costa Rica;
Dr D. Catsoulacos, Scientific Administrator, Manufacturing and Quality
Compliance, Compliance and Inspection, European Medicines Agency, London,
England; Mr J.-M. Caudron, Braine-le-Château, Belgium; Mr P. Cenizo, Southern
African Pharmaceutical Regulatory Affairs Association (SAPRAA), Randburg,
South Africa; Mr X. Chan, Project Manager, International Pharmaceutical
Federation, The Hague, the Netherlands; Dr B. Chapart, Pharma Review Manager,
Global Analytical Development, Sanofi-Aventis Pharma, Anthony, France;
Ms Cheah Nuan Ping, Director, Cosmetics & Cigarette Testing Laboratory,
Pharmaceutical Division, Applied Sciences Group, Health Sciences Authority,
Singapore; Dr X. Chen, Director, Division of Drug Distribution Supervision,
State Food and Drug Administration, Beijing, People's Republic of China;
Professor Y. Cherrah, Faculté de Médecine et Pharmacie, Rabat, Morocco;
Dr Y.H. Choi, Scientific Officer, Korea Food & Drug Administration, Cheongwongun,
Chungbuk, Republic of Korea; Cipla Limited, Mumbai, India; Ms I. Clamou,
Assistant Manager, Scientific,Technical and Regulatory Affairs, European
Federation of Pharmaceutical Industries and Associations, Brussels, Belgium;
Dr M. Cooke, Senior Manager, Global Quality, Operations, AstraZeneca,
Macclesfield, Cheshire, England; Dr C. Craft, Member, United States
Pharmacopeia International Health Expert Committee, Rockville, MD, USA;
Dr R.L. Dana, Senior Vice President, Regulatory Affairs and Parenteral Drug
Association Training and Research Institute, Parenteral Drug Association,
Bethesda, MD, USA; Mr M.M. Das, Barisha, Kolkata, India; Dr J. Daviaud, Senior
Pharmaceutical QA Officer, Pharmaceutical Procurement Unit, Global Fund to
Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland; Dr V. Davoust,
Quality & Regulatory Policy, Pharmaceutical Sciences, Pfizer Global Research &
Development, Paris, France; Professor T. Dekker, Research Institute for Industrial
Pharmacy, North-West University, Potchefstroom, South Africa; Dr M. Derecque-
Pois, Director General, European Association of Pharmaceutical Full-line
Wholesalers, Brussels, Belgium; Professor J.B. Dressman, Institut für
Pharmazeutische Technologie, Biozentrum, Johann Wolfgang Goethe-Universität,
Frankfurt am Main, Germany; Dr A.T. Ducca, Senior Director, Regulatory
Affairs, Healthcare Distribution Management Association, Arlington, VA, USA;
49